Alignment Healthcare, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$1.01B
↑+44.4% +$312Mvs FY2024 (Q4)
Gross Profit
$1.01B
↑+44.4% +$312Mvs FY2024 (Q4)
Operating Income
$879M
↑+48.4% +$287Mvs FY2024 (Q4)
Net Income
$875M
↑+49.1% +$288Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $1.01B | $701M |
| COGS | $0 | $0 |
| Gross Profit | $1.01B | $701M |
| R&D | $0 | $0 |
| SG&A | $126M | $102M |
| D&A | $8M | $7M |
| Other OpEx | $0 | $0 |
| Operating Income | $879M | $592M |
| Interest Exp. | $4M | $5M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $875M | $587M |
| Tax | $0 | $7K |
| Net Income | $875M | $587M |
QuarterCharts · SEC EDGAR data · ALHC · Comparing FY2025 (Q4) vs FY2024 (Q4)